E. Lynne Kelley, M.D., FACS

2019

In 2019, E. Lynne Kelley, M.D., FACS earned a total compensation of $970K as Former Chief Medical Officer at X4 Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$121,005
Option Awards$566,374
Salary$280,968
Other$1,604
Total$969,951

FACS received $566.4K in option awards, accounting for 58% of the total pay in 2019.

FACS also received $121K in non-equity incentive plan, $281K in salary and $1.6K in other compensation.

Rankings

In 2019, E. Lynne Kelley, M.D., FACS' compensation ranked 9,403rd out of 13,971 executives tracked by ExecPay. In other words, FACS earned more than 32.7% of executives.

ClassificationRankingPercentile
All
9,403
out of 13,971
33rd
Division
Manufacturing
3,776
out of 5,701
34th
Major group
Chemicals And Allied Products
1,435
out of 2,200
35th
Industry group
Drugs
1,224
out of 1,886
35th
Industry
Biological Products, Except Diagnostic Substances
272
out of 389
30th
Source: SEC filing on April 28, 2020.

FACS' colleagues

We found three more compensation records of executives who worked with E. Lynne Kelley, M.D., FACS at X4 Pharmaceuticals in 2019.

2019

Paula Ragan

X4 Pharmaceuticals

Chief Executive Officer

2019

Michael Gray

X4 Pharmaceuticals

Chief Executive Officer

2019

Adam Mostafa

X4 Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like